Applications and Products

How Archer NGS kits, controls and QC assays are being used.



Oct
15
2018

Common tests for ROS1 translocations in lung cancer

A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology highlights the limitations in common lab tests used to determine ROS1 status in lung cancer patients.


Oct
11
2018

Validation of the Archer FusionPlex Sarcoma kit

A paper published in The Journal for Molecular Diagnostics shows a direct comparison between the Archer FusionPlex Sarcoma panel and conventional methods for gene fusion detection, including fluorescence in situ hybridization (FISH) and reverse transcriptase-PCR (RT-PCR)


Oct
11
2018

Utility of Anchored Multiplex PCR for gene fusion detection®

Watch Dr. Cecilia Yeung's talk on using AMP™ technology for rapid identification of fusions in leukemias with Oxford Nanopore™ real-time sequencing from CGC 2018.


Sep
4
2018

New features in Archer Analysis 6.0

Archer Analysis has been updated to version 6.0, making it more powerful and versatile than ever.


Aug
22
2018

Sensitive and quantitative TP53 variant calling by NGS

The Archer® VariantPlex® p53 Kit combines superior TP53 gene coverage with robust enrichment chemistry and an easy-to-use workflow to give you confident, sensitive and quantitative TP53 variant calling.


Aug
1
2018

High coverage and noise characterization of CEBPA for sensitive and specific variant detection

CEBPA mutations are important prognostic indicators in AML, however detecting CEBPA mutations by NGS is challenging due to high GC content. Here, we show that AMP-based NGS provides superior coverage of CEBPA and we demonstrate the use of normalization datasets to assess the noise at each base position to calculate the per-base variant detection sensitivity across CEBPA, expressed as 95 MDAF.


Apr
4
2018

Cancer and ALK, RET, ROS1 gene fusions

Cancer is caused by mutations in specific genes. Many of these genes, including ALK, RET and ROS1, are called driver oncogenes because they are critical to the survival, growth and proliferation of cancer cells


Mar
20
2018

Full BRCA coverage to detect pathogenic variants by NGS

Full BRCA coverage to detect pathogenic variants by NGS


Feb
26
2018

NGS assays that match the pace of discovery

The modularity of Archer’s AMP chemistry allows users to create personalized NGS panels with the utmost flexibility and confidence. With coverage, panel uniformity and on-target reads at >90%, your custom assay is guaranteed to work for your applications. Additionally, any Archer assay is future-proof. When your team decides upon an updated list of key gene targets, simply add gene targets to an existing panel, or create an entirely new custom panel, without sacrificing performance.


Oct
2
2017

Input considerations for TCR and BCR sequencing

NGS is a powerful method to investigate the immune repertoire, and using RNA as the starting material has several advantages over DNA. Plus, sample-specific cell distributions and cell type-specific mRNA variations should be considered when analyzing the functional immune repertoire to minimize erroneous clonotyping.

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2018 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.